Home
FOLLOW US
         
          GöteborgBIO
        NEWSLETTER
      Welcome to sign up here!

                  

COMMUNICATION
ROOM
.
Photo:
Published: 2012-09-25 03:37
Denmark first to launch Plenadren
Duocort sold its drug candidate Plenadren to American Viropharma last year for approximately SEK 1 billion and the medicine will now enter its first market. Denmark will be the first country to sell Plenadren and will also constitute the first nation to supply a drug against Addison's disease in over 50 years.
Plenadren was developed by the virtual company Duocort with headquarters in West Sweden. The drug is based on hydrocortisone and has been developed for the treatment of adrenal insufficiency, also referred to as Addison's disease.

Plenadren has orphan drug status in the EU, Switzerland and the USA and was granted market authorisation by the European Medicines Agency at the start of November last year.

Share this page:
Tell a friend (opens in new window)
Updated: 2012-10-04
Comments
  1. maureen macpherson
    can you tell me how to buy plenadren from denmark
    # 2
    Thursday, 11 October at 12:07
  2. Idelle Port
    Do you know of a Danish or UK pharmacy that would supply me with plenadren using a prescription from a doctor in the United States?
    # 1
    Wednesday, 10 October at 21:22
Post a comment






LATEST NEWS
CALENDAR
VACANT POSITIONS

Vacant positions within the biotech and life science area in the Göteborg region.

Read more »

CURRENT CALLS

Here you find a list of current calls for proposals and applications for Life Science!

Read more »

GöteborgBIO  |  Medicinaregatan 8A  |  SE-413 46 Göteborg, Sweden  |  Phone: +46 31 61 24 02  | E-mail: contact@goteborgbio.se